Stay updated with breaking news from Immunologic Diseases. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vera Therapeutics, Inc. (VERA), a late clinical-stage biotechnology company focused on serious immunologic diseases, announced Thursday positive 72-week data from the open label extension or OLE period of its Phase 2b ORIGIN clinical trial of atacicept in participants with IgA nephropathy or IgAN.
Is reticulocyte hemoglobin content a better marker of iron deficiency anemia than ferritin and other traditional serum measurements?
Dermatological experts discuss challenges that are associated with the use of standard and emerging treatments in special patient population.
<p>HONG KONG SAR - <a href="https://www.media-outreach.com/">Media OutReach</a> - 26 April 2023 - A Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases - <b>SinoMab BioScience Limited (Stock Code: 3681.HK, "SinoMab" or the "Company")</b>, is pleased to announce that Phase III clinical trial of SinoMab's flagship product SM03 (Suciraslimab) for rheumatoid arthritis (RA) in China (Study No.</p>
Sen. Rand Paul and Rep. Chip Roy brought forward legislation to bust up the National Institute of Allergy and Infectious Diseases into three separate units led by three separate Senate-confirmed picks. Why? To make sure an Anthony Fauci-like dictator will never again emerge.